These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30497448)

  • 1. Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [
    Collantes M; Martínez-Vélez N; Zalacain M; Marrodán L; Ecay M; García-Velloso MJ; Alonso MM; Patiño-García A; Peñuelas I
    BMC Cancer; 2018 Nov; 18(1):1193. PubMed ID: 30497448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models.
    Campanile C; Arlt MJ; Krämer SD; Honer M; Gvozdenovic A; Brennecke P; Fischer CR; Sabile AA; Müller A; Ametamey SM; Born W; Schibli R; Fuchs B
    J Nucl Med; 2013 Aug; 54(8):1362-8. PubMed ID: 23801674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET SUVmax correlates with osteosarcoma histologic response to neoadjuvant chemotherapy: preclinical evaluation in an orthotopic rat model.
    Dutour A; Decouvelaere AV; Monteil J; Duclos ME; Roualdes O; Rousseau R; Marec-Bérard P
    J Nucl Med; 2009 Sep; 50(9):1533-40. PubMed ID: 19690032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.
    Im HJ; Kim TS; Park SY; Min HS; Kim JH; Kang HG; Park SE; Kwon MM; Yoon JH; Park HJ; Kim SK; Park BK
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):39-49. PubMed ID: 21953008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation.
    Arvanitis C; Bendapudi PK; Tseng JR; Gambhir SS; Felsher DW
    Cancer Biol Ther; 2008 Dec; 7(12):1947-51. PubMed ID: 18981708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomog- raphy/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients.
    Fidan AK; Uçmak G; Demirel BB; Efetürk H; Öztürk İ; Demirtaş Şenlik S; Esen Akkaş B; Ergürhan İlhan İ
    Turk J Med Sci; 2021 Jun; 51(3):1115-1122. PubMed ID: 33387988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
    Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
    BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
    Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.
    Benz MR; Evilevitch V; Allen-Auerbach MS; Eilber FC; Phelps ME; Czernin J; Weber WA
    J Nucl Med; 2008 Jul; 49(7):1038-46. PubMed ID: 18552153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma.
    Lee I; Byun BH; Lim I; Kim BI; Kong CB; Song WS; Cho WH; Koh JS; Lim SM
    Medicine (Baltimore); 2018 Sep; 97(37):e12318. PubMed ID: 30212975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and utility of MRI and dynamic
    Espedal H; Berg HF; Fonnes T; Fasmer KE; Krakstad C; Haldorsen IS
    J Transl Med; 2021 Sep; 19(1):406. PubMed ID: 34565386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI.
    Byun BH; Kong CB; Lim I; Kim BI; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1553-62. PubMed ID: 24652233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model.
    Huang S; Ren L; Beck JA; Phelps TE; Olkowski C; Ton A; Roy J; White ME; Adler S; Wong K; Cherukuri A; Zhang X; Basuli F; Choyke PL; Jagoda EM; LeBlanc AK
    Cancer Biother Radiopharm; 2023 Sep; 38(7):475-485. PubMed ID: 37253167
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study.
    Im HJ; Zhang Y; Wu H; Wu J; Daw NC; Navid F; Shulkin BL; Cho SY
    Radiology; 2018 Apr; 287(1):303-312. PubMed ID: 29357275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of biological parameters in head and neck cancer based on in vivo distribution of
    Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W
    Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography.
    Brody A; Crooks JC; French JM; Lang LG; Randall EK; Griffin LR
    Vet Comp Oncol; 2022 Sep; 20(3):541-550. PubMed ID: 35166445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.
    Kang WJ; Song EH; Park JY; Park YJ; Cho A; Song HT
    Nucl Med Biol; 2015 Sep; 42(9):728-33. PubMed ID: 26068116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma.
    Martínez-Vélez N; Xipell E; Vera B; Acanda de la Rocha A; Zalacain M; Marrodán L; Gonzalez-Huarriz M; Toledo G; Cascallo M; Alemany R; Patiño A; Alonso MM
    Clin Cancer Res; 2016 May; 22(9):2217-25. PubMed ID: 26603261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.